A specialist requests prior authorization for an off-label use of a biologic agent. What is the primary risk the PA reviewer must evaluate?
-
A
Network status of the requesting physician
-
B
Clinical evidence supporting safety and efficacy for the off-label indication
-
C
Whether the drug is available at a retail pharmacy
-
D
The member's deductible status